Rapport Therapeutics, Inc. Common Stock (RAPP)

Rapport Therapeutics, Inc. Common Stock (RAPP) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.3B; returns 1 day -2.3%, 1 week -5.9%, 1 year -1.0%.

Rapport Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of precision small molecule medicines for patients suffering from central nervous system (CNS) disorders.

Groups RAPP belongs to

• Biotechnology
• Clinical Stage Biotech
• Neuroscience
• CNS Disorders
• Biopharmaceutical
• Precision Medicine
• Healthcare
• Clinical Stage
• Epilepsy
• Drug Discovery

RAPP financial model: income statement, cash flow and balance sheet